Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
2,451
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness

Archana Thakura Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USACorrespondence[email protected]
View further author information
,
Johnson Unga Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USAView further author information
,
Elyse N. Tomaszewskib Department of Oncology, Barbara Ann Karmanos Cancer Institute and Wayne State University, Detroit, Michigan, USAView further author information
,
Amy Schienschanga Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USAView further author information
,
Timothy M. LaBriea Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USAView further author information
,
Dana L. Schalka Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USAView further author information
&
Lawrence G. Luma Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USAView further author information
 show all
Article: 1930883 | Received 05 Mar 2021, Accepted 13 May 2021, Published online: 01 Jun 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Himil Mahadevia, Pedro Luiz Serrano Uson Junior, Jing Wang, Mitesh Borad & Hani Babiker. (2024) An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Expert Opinion on Pharmacotherapy 25:1, pages 79-90.
Read now
Klara Dorman, Volker Heinemann, Sebastian Kobold, Michael von Bergwelt-Baildon & Stefan Boeck. (2022) Novel systemic treatment approaches for metastatic pancreatic cancer. Expert Opinion on Investigational Drugs 31:3, pages 249-262.
Read now
Bai Jing & Zhou Hui. (2022) Circular RNA_0033596 aggravates endothelial cell injury induced by oxidized low-density lipoprotein via microRNA-217-5p /chloride intracellular channel 4 axis. Bioengineered 13:2, pages 3410-3421.
Read now

Articles from other publishers (4)

Pooya Farhangnia, Ali-Akbar Delbandi, Maryam Sadri & Mahzad Akbarpour. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 46 .
Ewa Kubicka, Lawrence G. Lum, Manley Huang & Archana Thakur. (2022) Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia. Frontiers in Immunology 13.
Crossref
Chen Chen, Shujie Zhao, Xiangru Zhao, Lin Cao, Anand Karnad, Addanki P. Kumar & James W. Freeman. (2022) Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching. Cell Death & Disease 13:8.
Crossref
Zhenlu Li, Xing Huang, Weiming Hu & Huimin Lu. (2022) Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway. Tissue and Cell 77, pages 101787.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.